BN-82451 is a cyclooxygenase inhibitor potentially for the treatment of Huntington’s disease . References: Spinnewyn B, Mautino G, Marin JG, Rocher MN, Grandoulier AS, Ferrandis E, Auguet M, Chabrier PE. BN82451 attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neuropharmacology. 2011 Mar;60(4):692-700. doi: 10.1016/j.neuropharm.2010.11.019. Epub 2010 Dec 1. PubMed PMID: 21129389.

纯度：≥98%

CAS：663172-95-0